Contact Us
Drug Search Results
More Filters [+]

Ferric maltol

Alternative Names: ferric maltol, accrufer, ST10-021, ST10021
Latest Update: 2024-08-27
Latest Update Note: News Article

Product Description

a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease (Sourced from: https://pubmed.ncbi.nlm.nih.gov/26595432/)

Mechanisms of Action: Transferrin Agonist,Ferritin Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Austria | Belgium | Croatia | Czech | Denmark | Estonia | European Medicines Agency | Finland | Hungary | Iceland | Ireland | Italy | Latvia | Lithuania | Norway | Poland | Portugal | Slovakia | Slovenia | Spain | Sweden | Switzerland | United Kingdom | United States

Approved Indications: Anemia

Known Adverse Events: Abdominal Pain | Pain Unspecified | Constipation | Diarrhea | Flatulence

Company: Shield
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ferric maltol

Countries in Clinic: Puerto Rico, United Kingdom, United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Anemia, Iron-Deficiency|Colorectal Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PICoC

P3

Recruiting

Colorectal Cancer

2025-05-29

FORTIS

P3

Recruiting

Anemia, Iron-Deficiency

2024-04-01

56%

Recent News Events

Date

Type

Title

08/27/2024

News Article

 Kye Pharmaceuticals announces approval in Canada for ACCRUFeR® (ferric maltol) for the treatment of iron deficiency anemia in adult patients

07/17/2024

News Article

 SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

01/23/2024

News Article

 SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

03/21/2022

News Article

 KYE Pharmaceuticals Files Accrufer® New Drug Submission in Canada for the Treatment of Iron Deficiency

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions